Institutional Ownership
Medicus Pharma Ltd
CUSIP 58471K111*W EXP 11/15/202MDCXWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
6
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 60.6K | $57.6K |
| 2 | Private Advisor Group, LLC | 49.0K | $27.4K |
| 3 | Anson Funds Management LP | 42.4K | $19.5K |
| 4 | Empery Asset Management, LP | 12.1K | $11.5K |
| 5 | Connective Capital Management, LLC | 6.0K | $3.4K |
| 6 | Ubs Group AG | 1.5K | $820 |